Therapeutic depletion of myeloid lineage leukocytes in patients with generalized pustular psoriasis indicates a major role for neutrophils in the immunopathogenesis of psoriasis.
暂无分享,去创建一个
Hidetoshi Takahashi | T. Kanekura | M. Seishima | Y. Suga | A. Morita | K. Okuma | S. Ikeda | H. Eto | T. Etoh | Kazuo Takahashi | Y. Imai | T. Kanbara
[1] T. Tsai,et al. Etanercept use for psoriasis in Taiwan: a case series study , 2013, International journal of dermatology.
[2] S. Raychaudhuri. A Cutting Edge Overview: Psoriatic Disease , 2013, Clinical Reviews in Allergy & Immunology.
[3] Ryuichi Yamamoto,et al. The efficacy of intensive granulocyte and monocyte adsorption apheresis in a patient with Crohn's disease complicated by extensive subcutaneous aseptic neutrophilic abscesses. , 2012, Journal of Crohn's & colitis.
[4] S. Chimenti,et al. Psoriasis, from pathogenesis to therapeutic strategies: IL-21 as a novel potential therapeutic target. , 2012, Current pharmaceutical biotechnology.
[5] E. Berardesca,et al. Safety of anti-TNFα agents in the treatment of psoriasis and psoriatic arthritis , 2012, Immunopharmacology and immunotoxicology.
[6] É. Estève,et al. [Psoriasis: a systemic disease]. , 2012, Presse medicale.
[7] I. Maruyama,et al. Granulocyte and monocyte adsorption apheresis as an effective treatment for Reiter disease , 2012, Clinical and experimental dermatology.
[8] É. Estève,et al. Psoriasis : une maladie systémique , 2012 .
[9] M. Suárez-Fariñas,et al. Post-Therapeutic Relapse of Psoriasis after CD11a Blockade Is Associated with T Cells and Inflammatory Myeloid DCs , 2012, PloS one.
[10] C. Ritchlin. Strategies for Biomarker Development in Psoriatic Disease: A Report from the GRAPPA 2010 Annual Meeting , 2012, The Journal of Rheumatology.
[11] G. Zanni. Psoriasis: issues far more serious than cosmetic. , 2012, The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists.
[12] A. Pietrzak,et al. Cytokine network in psoriasis revisited. , 2011, European cytokine network.
[13] K. Okuma,et al. Granulocyte and monocyte adsorption apheresis for generalized pustular psoriasis , 2011, The Journal of dermatology.
[14] K. Iwatsuki,et al. Beneficial effects of neutrophil-targeted therapy for pyoderma gangrenosum associated with ulcerative colitis. , 2011, European journal of dermatology : EJD.
[15] Y. Okumura,et al. Generalized Pustular Psoriasis Successfully Treated With Granulocyte and Monocyte Adsorption Apheresis , 2011, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[16] Takayuki Yamamoto,et al. Daily granulocyte and monocyte adsorptive apheresis in patients with active ulcerative colitis: a prospective safety and feasibility study , 2011, Journal of Gastroenterology.
[17] J. Korzenik,et al. Psoriasis Associated With Anti-Tumor Necrosis Factor Therapy in Inflammatory Bowel Disease , 2011 .
[18] D. Aly,et al. Serum levels of interleukin‐8, tumor necrosis factor‐α and γ‐interferon in Egyptian psoriatic patients and correlation with disease severity , 2011, The Journal of dermatology.
[19] M. Eberhardson,et al. The mode of actions of the Adacolumn therapeutic leucocytapheresis in patients with inflammatory bowel disease: a concise review , 2011, Clinical and experimental immunology.
[20] T. Matsui,et al. An Open-Label Prospective Randomized Multicenter Study Shows Very Rapid Remission of Ulcerative Colitis by Intensive Granulocyte and Monocyte Adsorptive Apheresis as Compared With Routine Weekly Treatment , 2009, The American Journal of Gastroenterology.
[21] T. Hibi,et al. Treating ulcerative colitis by Adacolumn therapeutic leucocytapheresis: clinical efficacy and safety based on surveillance of 656 patients in 53 centres in Japan. , 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.
[22] T. Hibi,et al. Randomized , Double-Blind , Sham-Controlled Study of ranulocyte / Monocyte Apheresis for Active Ulcerative Colitis , 2008 .
[23] M. Kikuyama,et al. Adsorptive Depletion of Elevated Proinflammatory CD14+CD16+DR++ Monocytes in Patients With Inflammatory Bowel Disease , 2008, The American Journal of Gastroenterology.
[24] J. Arenas,et al. Regulatory T cells in patients with inflammatory bowel diseases treated with adacolumn granulocytapheresis. , 2008, World journal of gastroenterology.
[25] M. Seishima,et al. Efficacy of Granulocyte and Monocyte Adsorption Apheresis for Pustular Psoriasis , 2008, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[26] J. Saurat,et al. Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION) , 2007, The British journal of dermatology.
[27] I. Bjarnason,et al. Therapeutic leukocytapheresis for inflammatory bowel disease. , 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.
[28] Katsuyuki Tozawa,et al. Demonstration of Low-Regulatory CD25High+CD4+ and High-Pro-inflammatory CD28−CD4+ T-Cell Subsets in Patients with Ulcerative Colitis: Modified by Selective Granulocyte and Monocyte Adsorption Apheresis , 2007, Digestive Diseases and Sciences.
[29] A. Saniabadi,et al. Impact of selective leukocytapheresis on mucosal inflammation and ulcerative colitis: Cytokine profiles and endoscopic findings , 2006, Inflammatory bowel diseases.
[30] I. Maruyama,et al. Granulocyte and Monocyte Adsorption Apheresis (GCAP) for Refractory Skin Diseases Caused by Activated Neutrophils and Psoriatic Arthritis: Evidence that GCAP Removes Mac‐1‐Expressing Neutrophils , 2006, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[31] I. Maruyama,et al. Granulocyte and monocyte adsorption apheresis for leg ulcers in a patient with rheumatoid arthritis. , 2005, Journal of the American Academy of Dermatology.
[32] M. Gassull,et al. Granulocyteaphaeresis in steroid‐dependent inflammatory bowel disease: a prospective, open, pilot study , 2004, Alimentary pharmacology & therapeutics.
[33] Arthur Rook,et al. Rook's Textbook of Dermatology , 2004 .
[34] Tatsuo Tanaka,et al. Correlation of Serum Soluble TNF-α Receptors I and II Levels with Disease Activity in Patients with Ulcerative Colitis , 2004, American Journal of Gastroenterology.
[35] M. Rybojad,et al. High frequency of cholestasis in generalized pustular psoriasis: Evidence for neutrophilic involvement of the biliary tract , 2004, Hepatology.
[36] A. Saniabadi,et al. Adhesion dependent release of hepatocyte growth factor and interleukin-1 receptor antagonist from human blood granulocytes and monocytes: Evidence for the involvement of plasma IgG, complement C3 and β2 integrin , 2004, Inflammation Research.
[37] K. Fukunaga,et al. Detection of Specific IgE Antibodies to Nafamostat Mesilate as an Indication of Possible Adverse Effects of Leukocytapheresis using Nafamostat Mesilate as Anticoagulant , 2004, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[38] Katsuhiro Hayashi,et al. Hepatocyte Growth Factor Facilitates Colonic Mucosal Repair in Experimental Ulcerative Colitis in Rats , 2003, Journal of Pharmacology and Experimental Therapeutics.
[39] T. Tezuka,et al. Therapeutic guidelines for the treatment of generalized pustular psoriasis (GPP) based on a proposed classification of disease severity , 2003, Archives of Dermatological Research.
[40] I. Bjarnason,et al. Adacolumn, an Adsorptive Carrier Based Granulocyte and MonocyteApheresis Device for the Treatment of Inflammatory and RefractoryDiseases Associated with Leukocytes , 2003, Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy.
[41] T. Espevik,et al. The Proinflammatory CD14+CD16+DR++ Monocytes Are a Major Source of TNF1 , 2002, The Journal of Immunology.
[42] W. Gong,et al. Expression of CCR6 and CD83 by cytokine-activated human neutrophils. , 2000, Blood.
[43] H. Tagami,et al. Role of neutrophils in induction of acute inflammation in T‐cell‐mediated immune dermatosis, psoriasis: A neutrophil‐associated inflammation‐boosting loop , 2000, Experimental dermatology.
[44] S. Nikolaus,et al. Increased secretion of pro-inflammatory cytokines by circulating polymorphonuclear neutrophils and regulation by interleukin 10 during intestinal inflammation , 1998, Gut.
[45] A. Finlay,et al. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.
[46] C A Smith,et al. Soluble tumor necrosis factor (TNF) receptors are effective therapeutic agents in lethal endotoxemia and function simultaneously as both TNF carriers and TNF antagonists. , 1993, Journal of immunology.
[47] R. Thompson,et al. Blocking IL-1: interleukin 1 receptor antagonist in vivo and in vitro. , 1991, Immunology today.
[48] S. Allen,et al. Electron microscopic features in generalized pustular psoriasis. , 1987, The Journal of investigative dermatology.
[49] G. Lazarus,et al. Polymorphonuclear leukocytes: possible mechanism of accumulation in psoriasis. , 1977, Science.
[50] N. Hoede,et al. [Psoriasis, a systemic disease]. , 1974, Der Internist.
[51] K. Reich,et al. Psoriasis--new insights into pathogenesis and treatment. , 2009, Deutsches Arzteblatt international.
[52] G. Haroske,et al. Tumor necrosis factor-alpha inhibitor-induced psoriasis or psoriasiform exanthemata: first 120 cases from the literature including a series of six new patients. , 2008, American journal of clinical dermatology.
[53] G. Haroske,et al. Tumor Necrosis Factor-α Inhibitor-Induced Psoriasis or Psoriasiform Exanthemata , 2008 .
[54] I. Nakamura,et al. Treatment of pyoderma gangrenosum associated with Crohn's disease , 2003, American Journal of Gastroenterology.
[55] A. Munakata,et al. Safety and efficacy of granulocyte and monocyte adsorption apheresis in patients with active ulcerative colitis: A multicenter study , 2001, Journal of clinical apheresis.
[56] M. Cassatella. The production of cytokines by polymorphonuclear neutrophils. , 1995, Immunology today.